Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
- PMID: 40650213
- PMCID: PMC12250386
- DOI: 10.3390/ijms26136437
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Abstract
Statistical data demonstrate a concurrent rise in smoking prevalence and mental disorders, such as depression and anxiety, which may be attributed to contemporary lifestyle factors, including social media and recent global events. This indicates a potential correlation between these trends, as individuals with mental disorders may engage in smoking as a form of self-medication to alleviate anxiety. However, smoking is harmful and increases the risk of many diseases. Therefore, smoking cessation strategies are increasingly being considered. Nicotine is a naturally produced alkaloid in plants that makes smoking so addictive. Unfortunately, the public's lack of understanding of the effects of nicotine leads to misleading claims in the public and media about its biological effects. Thus, current narrative literature review is focused on the examination of the biological effects of organic nicotine from various angles, considering the psychological aspects of addiction and the immune system. Analysis of recent data showed that nicotine not only causes addiction but also has therapeutic benefits in certain diseases (depression, anxiety, schizophrenia) and has anti-inflammatory properties (autoimmunity, neurodegenerative diseases), and a deeper understanding and a broader approach to its effects is needed.
Keywords: addiction; autoimmunity; cancer; cardiovascular diseases; cytokines; harm reduction; inflammation; neurodegenerative diseases; nicotinic acetylcholine receptors; smoking.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2023 May 5;5:CD006103. doi: 10.1002/14651858.CD006103.pub8. PMID: 27158893 Free PMC article. Updated.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 May 09;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. PMID: 22513936 Updated.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. PMID: 21328282 Updated.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. PMID: 21154363 Updated.
References
-
- Tobacco. [(accessed on 11 February 2025)]. Available online: https://www.who.int/news-room/fact-sheets/detail/tobacco.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources